Prof Robert Hawkins MA MB BS PhD FRCP

Honorary Professor

Full contact details
View graph of relations

Publications

  1. 2022
  2. Accepted/In press

    Acute and chronic cardiopulmonary effects of high dose interleukin-2 therapy: an observational magnetic resonance imaging study

    Lagan, J., Naish, J. H., Campbell, C., Chow, S., Pillai, M., Bradley, J., Francis, L., Clark, D., Macnab, A., Dobson, R., Schelbert, E. B., Schmitt, M., Hawkins, R. & Miller, C. A., 24 May 2022, (Accepted/In press) In: Diagnostics.

    Research output: Contribution to journalArticlepeer-review

  3. 2021
  4. Published

    Clinical Feasibility and Treatment Outcomes with Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients with Advanced Cutaneous Melanoma.

    Hawkins, R. E., Jiang, Y., Lorigan, P. C., Thistlethwaite, F. C., Pillai, M., Thomas, M., Kirilova, N., Bridgeman, J. S., Kueberuwa, G., Guest, R. S. & Roberts, Z. J., Jul 2021, In: Cancer Research. 81, 13

    Research output: Contribution to journalMeeting Abstractpeer-review

  5. 2020
  6. Published

    Massively parallel interrogation and mining of natively paired human TCRαβ repertoires

    Spindler, M. J., Nelson, A. L., Wagner, E. K., Oppermans, N., Bridgeman, J. S., Heather, J. M., Adler, A. S., Asensio, M. A., Edgar, R. C., Lim, Y. W., Meyer, E. H., Hawkins, R. E., Cobbold, M. & Johnson, D. S., 16 Mar 2020, In: Nature biotechnology. 38, 5, p. 609-619 11 p.

    Research output: Contribution to journalArticlepeer-review

  7. 2019
  8. Published

    Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

    Rini, B. I., Powles, T., Atkins, M. B., Escudier, B., McDermott, D. F., Suarez, C., Bracarda, S., Stadler, W. M., Donskov, F., Lee, J. L., Hawkins, R., Ravaud, A., Alekseev, B., Staehler, M., Uemura, M., De Giorgi, U., Mellado, B., Porta, C., Melichar, B., Gurney, H., & 12 othersBedke, J., Choueiri, T. K., Parnis, F., Khaznadar, T., Thobhani, A., Li, S., Piault-Louis, E., Frantz, G., Huseni, M., Schiff, C., Green, M. C. & Motzer, R. J., 15 Jun 2019, In: The Lancet. 393, 10189, p. 2404-2415 12 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

    Schmidinger, M., Bamias, A., Procopio, G., Hawkins, R., Sanchez, A. R., Vázquez, S., Srihari, N., Kalofonos, H., Bono, P., Pisal, C. B., Hirschberg, Y., Dezzani, L., Ahmad, Q. & Jonasch, E., 2019, In: Oncologist.

    Research output: Contribution to journalArticlepeer-review

  10. Published

    Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

    Hall, P. E., Shepherd, S. T. C., Brown, J., Larkin, J., Jones, R., Ralph, C., Hawkins, R., Chowdhury, S., Boleti, E., Bahl, A., Fife, K., Webb, A., Crabb, S. J., Geldart, T., Hill, R., Dunlop, J., McLaren, D., Ackerman, C., Wimalasingham, A., Beltran, L., & 2 othersNathan, P. & Powles, T., 2019, In: European Urology Focus.

    Research output: Contribution to journalArticlepeer-review

  11. 2018
  12. Published

    Ex vivo expanded Tumour Infiltrating Lymphocytes (TILs) from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

    Owens, G., Price, M., Cheadle, E., Hawkins, R., Gilham, D. & Edmondson, R., Oct 2018, In: Cancer Immunology, Immunotherapy.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

    Kueberuwa, G., Zheng, W., Kalaitsidou, M., Gilham, D. & Hawkins, R., 2018, In: Journal of Visualized Experiments. 140

    Research output: Contribution to journalArticlepeer-review

  14. 2017
  15. Published

    CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo

    Kueberuwa, G., Gornall, H., Alcantar Orozco, E. M., Bouvier, D., Kapacee, Z. A., Hawkins, R. & Gilham, D., Dec 2017, In: Journal for ImmunoTherapy of Cancer. 5, 14

    Research output: Contribution to journalArticlepeer-review

  16. Published

    Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

    Chamie, K., Donin, N. M., Klöpfer, P., Bevan, P., Fall, B., Wilhelm, O., Störkel, S., Said, J., Gambla, M., Hawkins, R. E., Jankilevich, G., Kapoor, A., Kopyltsov, E., Staehler, M., Taari, K., Wainstein, A. J. A., Pantuck, A. J. & Belldegrun, A. S., 1 Jul 2017, In: JAMA oncology. 3, 7, jamaoncol.2016.4419.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next